These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5172404)

  • 1. [Long-term combined administration of dromostanolone propionate (Mastisol) and cyclophosphamide (Endoxan) for advanced breast cancer after surgical hormone therapy].
    Nomura Y; Hattori T; Abe Y; Iguchi K
    Gan No Rinsho; 1971 Dec; 17(12):899-904. PubMed ID: 5172404
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined hormone therapy in advanced breast cancer. Triple-blind study of 68 patients treated with dromostanolone and fluorometholone.
    Gaertner RA; Lewison EF; Finney GG; Montague AC
    Johns Hopkins Med J; 1968 Sep; 123(3):138-41. PubMed ID: 4876823
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of CAF'-endocrine therapy on advanced and recurrent breast cancer].
    Une Y; Sato Y; Kagaya H; Miyata S; Matsuoka S; Uchino J; Yakura Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2778-81. PubMed ID: 6548892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Internal endocrine therapy of breast cancer].
    Yoshida M; Miura S
    Gan To Kagaku Ryoho; 1984 May; 11(5):989-98. PubMed ID: 6372698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mastisol (2-alpha-methylandrostan-17-beta-ol-3-one propionate) and testosterone propionate in the treatment of advanced and recurrent cancer of the breast.
    Amaaki T; Enomoto K; Shimada S; Nagai K; Minagawa N
    Nihon Geka Hokan; 1969 Jul; 38(4):652-7. PubMed ID: 5394603
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
    Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
    Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of testosterone decanoate, drostanolone and testololactone in disseminated breast cancer--a randomized clinical study.
    Rieche K; Wolff G
    Arch Geschwulstforsch; 1975; 45(5):485-8. PubMed ID: 1243528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
    Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of dromostanolone propionate for mastopathy--with special reference to screening of breast cancer].
    Takeuchi S; Yoshida M
    Saishin Igaku; 1967 May; 22(5):1049-54. PubMed ID: 5630583
    [No Abstract]   [Full Text] [Related]  

  • 10. Thio-tepa and endoxan in combined treatment of breast cancer (cooperative trial).
    Blokhina NG; Karev NI
    Radiobiol Radiother (Berl); 1974; 15(3):357-60. PubMed ID: 4217461
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remission maintenance with cytostatic long-term therapy in metastatic breast cancer].
    Beaufort F
    Onkologie; 1982 Aug; 5 Suppl():52-4. PubMed ID: 6813783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone and cyclophosphamide in patients with advanced breast cancer.
    Ehninger G; Weible KH; Heidemann EG; Waller HD
    Cancer Treat Rep; 1984 Oct; 68(10):1283-4. PubMed ID: 6525600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with dromostanolone propionate (NSC-12198) in breast carcinoma.
    Seay DG; Bradshaw JD; Nicol NT
    Cancer Chemother Rep; 1972 Feb; 56(1):89-92. PubMed ID: 5067664
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer.
    Dittrich C; Petruzelka L; Vodvarka P; Gneist M; Janku F; Kysela T; Melemed A; Latz J; Simms L; Krejcy K
    Clin Cancer Res; 2006 Dec; 12(23):7071-8. PubMed ID: 17145830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination drug-hormone therapy of the advanced stages of breast carcinoma].
    Fazio M; Cavallero P; Rattalino G; Sartoris S; Vergnano F
    Minerva Ginecol; 1976; 28(7-8):623-9. PubMed ID: 1037112
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence.
    Metz JM; Schultz DJ; Fox K; Glick J; Solin LJ
    Cancer J Sci Am; 1999; 5(2):77-83. PubMed ID: 10198729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.